Swiss National Bank trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 1.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 222,100 shares of the biotechnology company’s stock after selling 3,700 shares during the quarter. Swiss National Bank’s holdings in Axon Enterprise were worth $57,375,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Westfield Capital Management Co. LP raised its position in Axon Enterprise by 184.3% in the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after buying an additional 451,350 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its position in Axon Enterprise by 18.4% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after acquiring an additional 16,230 shares during the period. BKM Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $32,000. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in Axon Enterprise by 0.3% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock valued at $29,320,000 after acquiring an additional 495 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at about $39,907,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Trading Up 0.6 %
AXON opened at $318.55 on Monday. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87. The firm has a market capitalization of $24.04 billion, a PE ratio of 138.50 and a beta of 0.91. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The company’s 50-day moving average is $308.83 and its 200 day moving average is $265.60.
Analysts Set New Price Targets
Several research firms recently issued reports on AXON. TheStreet lowered shares of Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. JMP Securities lifted their target price on Axon Enterprise from $320.00 to $375.00 and gave the company a “market outperform” rating in a research report on Wednesday, May 1st. Barclays raised their price objective on Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. Finally, The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $323.09.
View Our Latest Report on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- What to Know About Investing in Penny Stocks
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
- The “How” and “Why” of Investing in 5G Stocks
- Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.